Fezolinetant- A novel NK3R antagonist for treating postmenopausal vasomotor symptoms

Madam, It has been estimated that up to 80% of postmenopausal women experience vasomotor symptoms (VMS) such as hot flushes, night sweats, mood swings and difficulty in concentrating1. These symptoms markedly affect different aspects of daily life for women, including, sleep, mental well-being, s...

書誌詳細
出版年:	Journal of the Pakistan Medical Association
主要な著者:	Saqib Ali, Muhammad Affan Ilyas
フォーマット:	論文
言語:	英語
出版事項:	Pakistan Medical Association 2024-07-01
オンライン･アクセス:	https://jpma.org.pk/index.php/public_html/article/view/20096

類似資料

Targeting vasomotor symptoms with the new drug fezolinetant – an expert overview
著者:: Rossella E. Nappi, 等
出版事項: (2025-12-01)

“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
著者:: Ayesha Shaukat, 等
出版事項: (2023-10-01)

Fezolinetant’s efficacy and safety in treatment of vasomotor symptoms in postmenopausal women: a meta-analysis and GRADE evaluation of randomized controlled trials
著者:: Abdallah R. Allam, 等
出版事項: (2025-01-01)

Efficacy and safety of fezolinetant and its different doses in the treatment of vasomotor symptoms in menopausal women: a systematic review and meta-analysis
著者:: Rahma Abdelaziz Ismail, 等
出版事項: (2025-06-01)

Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial
著者:: Qi Yu, 等
出版事項: (2024-05-01)

Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)
著者:: Xiangyan Ruan, 等
出版事項: (2024-05-01)

Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER’S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms
著者:: Paul C Langley
出版事項: (2023-03-01)

Fezolinetant: The rescue at menopause
著者:: Kavitha Raju Manjooran
出版事項: (2023-10-01)

The efficacy and safety of genistein in the treatment of vasomotor symptoms in postmenopausal women (research review)
著者:: I V Kuznetsova
出版事項: (2013-06-01)

Breakthroughs in women's health for treating vasomotor symptoms
著者:: Peng-Hui Wang, 等
出版事項: (2024-11-01)

Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study
著者:: Seul Koo, 等
出版事項: (2017-12-01)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
著者:: Melissa Conklin, 等
出版事項: (2023-06-01)

Association Between Body Mass Index and Moderate-to-Severe Vasomotor Symptoms in Thai Postmenopausal Women
著者:: Kitirat Techatraisak, 等
出版事項: (2019-09-01)

Association Between Body Mass Index and Moderate-to-Severe Vasomotor Symptoms in Thai Postmenopausal Women
著者:: Kitirat Techatraisak, 等
出版事項: (2019-09-01)

Role of the pharmacist in the management of postmenopausal breast cancer treatment with vasomotor symptoms: A case report
著者:: Megan R. Undeberg, 等
出版事項: (2023-09-01)

Postmenopausal women's experiences of a resistance training intervention against vasomotor symptoms: a qualitative study
著者:: Emilia Berin, 等
出版事項: (2022-07-01)

Prevalence, severity, and association of serum follicle-stimulating hormone level with vasomotor and genitourinary symptoms in perimenopausal and postmenopausal women
著者:: Priya Saini, 等
出版事項: (2025-07-01)

Characterization and Treatment Patterns of Peri/Menopausal and Postmenopausal Women with and Without Vasomotor Symptoms in a Retrospective Database Study
著者:: Lena Charafi, 等
出版事項: (2025-01-01)

Fezolinetant - a potential alternative to hormone replacement therapy for menopausal women
著者:: Hassan Mehmood, 等
出版事項: (2024-09-01)

Menopause part I: Vasomotor symptoms (I)
著者:: Peng-Hui Wang, 等
出版事項: (2025-03-01)

The Effects of a Non-Hormonal NK3R Antagonist Nutritional Supplement on Joint Discomfort and Quality of Life Parameters in Peri- and Postmenopausal Females
著者:: Michaela Alesi, 等
出版事項: (2025-05-01)

Revolutionizing menopause management: Nonhormonal therapy for vasomotor symptoms
著者:: Shanzey Rai, 等
出版事項: (2024-12-01)

Psychosomatic and vasomotor symptom changes during transition to menopause
著者:: Areti Augoulea, 等
出版事項: (2019-06-01)

Vasomotor and physical menopausal symptoms are associated with sleep quality.
著者:: Min-Ju Kim, 等
出版事項: (2018-01-01)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
著者:: Uml, 等
出版事項: (2012-07-01)

Investigation of the relationship between personality characteristics and vasomotor symptoms in menopausal women
著者:: Mahboubeh Ghorbani, 等
出版事項: (2016-01-01)

Development, Validation and Pilot Testing of a Multidimensional Rehabilitation Protocol for Autonomic, Vasomotor and Cognitive Symptoms in Postmenopausal Women: A Two Phasic Feasibility Study
著者:: Poornima Maurya, 等
出版事項: (2026-07-01)

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
著者:: DiBonaventura MD, 等
出版事項: (2013-05-01)

Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
著者:: Utian Wulf H
出版事項: (2005-08-01)

RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
著者:: Kalkan R, 等
出版事項: (2020-08-01)

A 2-year follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor symptoms, quality of life and cardiovascular risk markers
著者:: Sigrid Nilsson, 等
出版事項: (2024-09-01)

Epidemiology of Vasomotor Rhinitis
著者:: Russell A. Settipane, MD
出版事項: (2009-01-01)

An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects
著者:: Li Y, 等
出版事項: (2025-03-01)

The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms
著者:: F. N. Tuysuzoglu, 等
出版事項: (2020-04-01)

Soy use and vasomotor symptoms: Soy Estrogen Alternative follow-up study
著者:: Mara Z Vitolins, 等
出版事項: (2010-11-01)

Pharmacotherapy in patients with vasomotor disorders
著者:: C.K.M. Boerhout, 等
出版事項: (2023-10-01)

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
著者:: Paweł K. Halik, 等
出版事項: (2020-08-01)

Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population‐Based Study
著者:: Sigrid Nilsson, 等
出版事項: (2024-09-01)

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis
著者:: Joshua R. Rhodes, 等
出版事項: (2023-08-01)

Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
著者:: Khan SJ, 等
出版事項: (2023-02-01)